RUNX2 and neoplasm: Indeed several studies reported the over-expression of RUNX2 in tumor derived from epithelial tissues, including: thyroid [6, 7], breast [8], pancreas [9, 10], prostate [11], lung [12, 13], melanoma [14], glioma [15], colorectal [16] and osteosarcoma [17].